CDMO Pricing For Viral Vectors And Cell & Gene Services
Source: Ajinomoto Bio-Pharma Services
Kenneth Lock of Carisma Therapeutics relates his experiences when it comes to costs and pricing from CDMOs on viral vectors and the CGT industry, but everyone will find some key and actionable information in his comments.
View the full presentation on-demand here.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
Ajinomoto Bio-Pharma Services
This website uses cookies to ensure you get the best experience on our website. Learn more